期刊文献+

沙利霉素增强肝癌细胞对5-氟尿嘧啶敏感性及其作用机制研究

Sensitivity and mechanism of salinomycin affecting the liver cancer cells to 5-fluorouracil
下载PDF
导出
摘要 目的研究沙利霉素(Sal)增强肝癌细胞对5-氟尿嘧啶(5-FU)敏感性及其机制,为抗药性原发性肝癌患者提供新的治疗方案。方法选用肝癌细胞株HepG2、SMMC-7721和MHCC-97H为研究对象,运用MTT方法,克隆形成实验,流式细胞仪检测Sal和5-FU联合作用下对肝癌细胞增殖抑制率、克隆形成、细胞凋亡和肿瘤干细胞增殖的影响;Western-blot方法检测Sal和5-FU联合作用对Wnt/β-catenin信号通路的影响。结果 Sal和5-FU联合作用能够显著抑制肝癌细胞增殖和克隆形成并诱导细胞凋亡,具有协同作用;5-FU能促进肝癌肿瘤干细胞增殖,而Sal降低5-FU的这一作用;同时Sal能抑制Wnt/β-catenin信号通路。结论 Sal通过抑制Wnt/β-catenin信号通路增强肝癌细胞对5-FU的敏感性;Sal和5-FU联合作用为抗药性原发性肝癌患者提供新的治疗方案。 Objective To study salinomycin(Sal)enhance the sensitivity of liver cancer cell to 5-fluorouracil(5-FU)and its mechanism,and to provide drug-resistant primary hepatocellular carcinoma(HCC)patients with a new treatment.Methods Hepatoma cell line HepG2,SMMC-7721,MHCC-97 H were used for the research.The effect of Sal combined with 5-FU on the cell proliferation inhibition rate,colony formation,apoptosis and tumor stem cell proliferation were detected by the MTT assay,colony formation assay,flow cytometry.And the effect on Wnt/-catenin when Sal combined with 5-FU were detected by Western-blot.Results Sal combined with 5-FU significantly inhibited the liver cancer cell proliferation and colony formation and induced cell apoptosis,showed the synergistic effect.5-FU promoted the proliferation of hepatocarcinoma stem,but Sal reduced the function of 5-FU.At the same time Sal could inhibit the Wnt/-catenin signal pathway.Conclusion The Sal can increase the sensitivity of hepatocellular carcinoma cells to 5-FU by inhibiting Wnt/-catenin signal pathway;Sal combined with 5-FU could provide drug-resistant HCC patients with a new treatment.
出处 《重庆医学》 CAS 北大核心 2015年第28期3903-3907,共5页 Chongqing medicine
基金 湖北省教育厅指导项目(B2014054)
关键词 肝肿瘤 氟尿嘧啶 沙利霉素 药物协同作用 抗药性 liver neoplasms fluorouracil salinomycin drug synergism drug resistance
  • 相关文献

参考文献24

  • 1Siegel R, Naishadham D, Jemal A. Cancer statistics [J]. JAMA,2013,310(9) :982.
  • 2Cilley J,Mulcahy MF. Adjuvant therapy for colon cancer [J]. Curt Oncol Rep,2006,8(3):161-166.
  • 3Martin M, Pienkowski T, Mackey J, et al. Adjuvant do- cetaxel for node-positive breast cancer[J]. N Engl J Med, 2005,352 (22) : 2302-2313.
  • 4Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradio- therapy after surgery compared with surgery alone for ad- enocarcinoma of the stomach or gastroesophageal junction [J]. N Engl J Meal,2001,345(10):725-730.
  • 5Lin DY,Lin SM,Yf L. Non-surgical treatment of hepato- cellular carcinoma[J]. J Gastroenterol Hepatol, 1997,12 (9/10) : 319-328.
  • 6Yoo BK, Gredler R, Vozhilla N, et al. Identification of genes conferring resistance to 5-fluorouracil[J]. Proc Natl Acad Sci U S A,2009,106(31):12938-12943.
  • 7Haraguchi N,Ishii H,Mimori K,et al. CD133 is a thera- peutic target in human liver cancer stem cells[J]. J Clin Invest,2010,120(9) :3326-3339.
  • 8Dean M,Fojo T,Bates S. Tumour stem cells and drug re- sistance[J]. Nat Rev Cancer,2005,5(4):275-284.
  • 9Huntly BJ, Gilliland DG. Cancer biology: summing up cancer stem cells[J]. Nature, 2005, 435 (746): 1169- 1170.
  • 10Collura A, Marisa L,Trojan D, et al. Extensive character- ization of sphere models established from colorectal canc- er cell lines[J]. Cell Mol Life Sci, 2013,70(4) : 729-742.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部